Dna X (SONM) Other Working Capital Changes (2018 - 2026)

Dna X has reported Other Working Capital Changes for 9 years, with the latest figure at -$1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 55533.33% year-over-year to -$1.7 million; the trailing twelve-month figure through Mar 2026 stood at -$1.6 million (down 155.04% YoY), and the FY2025 full-year result was $21000.0, down 99.29% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$1.7 million, down from $832000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $2.3 million in Q4 2024, with the low at -$1.7 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $101203.6 across 5 years, with a median of $5538.0 in 2022.
• Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 18219.93% — and 2026, when it sank 55533.33%.
• Dna X's Other Working Capital Changes stood at $587000.0 in 2022, then plunged by 112.61% to -$74000.0 in 2023, then soared by 3220.27% to $2.3 million in 2024, then plunged by 63.97% to $832000.0 in 2025, then plunged by 299.88% to -$1.7 million in 2026.
• The last three Other Working Capital Changes figures came in at -$1.7 million (Q1 2026), $832000.0 (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.